Call for Abstract
Scientific Program
9th Indo Global Summit on Cancer Therapy, will be organized around the theme “Precision therapeutics and curative approaches to curb cancer”
Indo Cancer Summit 2015 is comprised of 12 tracks and 62 sessions designed to offer comprehensive sessions that address current issues in Indo Cancer Summit 2015.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Advances in Stage - I
- Track 1-2Advances in Stage - II
- Track 1-3Advances in Stage - III
- Track 1-4Advances in Stage - IV
- Track 2-1Functional genomics in drug discovery and development
- Track 2-2 Therapeutic antibodies and cancer vaccines
- Track 2-3 Novel drug delivery system and cancer drug designing
- Track 2-4 Nanotechnology in cancer drugs
- Track 2-5 Anticancer drugs in global market: economy and their cost effectiveness
- Track 2-6 Cancer clinical trails
- Track 2-7Regulatory issues in cancer research
- Track 3-1Advances in Liver Cancer Treatment
- Track 3-2Advances in Prostate Cancer Treatment
- Track 3-3Breast Cancer Treatment
- Track 3-4Cancer Chemotherapy
- Track 4-1Ayurveda- Cancer basics & therapeutics
- Track 4-2Homoeopathy- Cancer basics & therapeutics
- Track 4-3Siddha- Cancer basics & therapeutics
- Track 4-4Unani- Cancer basics & therapeutics
- Track 4-5Yoga & Naturopathy- cancer basics & therapeutics
- Track 5-1Cancer screening and early detection & prevention
- Track 5-2 Molecular diagnostics
- Track 5-3 Personalized genomics and clinical biomarkers
- Track 5-4 Digital cancer pathology and imaging
- Track 5-5 Chemotherapy and biological therapeutics
- Track 5-6 Innovational combinational therapy
- Track 6-1 Current Trends and Innovations in Metabolomics
- Track 6-2Stem cell mediated immuno gene therapy for tumors
- Track 6-3 Cancer biomarkers, Diagnostic and Prognostic Cancer Biomarkers
- Track 6-4Tumour-host interactions,Nuclear responses and tumorigenesis
- Track 6-5 Challenges and new opportunities with antibody drugs
- Track 6-6Cancer-induced immunosuppressive cells.
- Track 7-1Liver Cancer prognosis
- Track 7-2Brain Cancer prognosis
- Track 7-3Squamous cell Cancer prognosis
- Track 7-4Metastatic prognosis
- Track 8-1 Molecular and cellular oncology
- Track 8-2Cancer Genomics and Systems Biology
- Track 8-3Tumor microenvironment or tumor immunology and immune therapy
- Track 8-4 Cancer stem cells
- Track 8-5 Metabolic complexity of signal transduction
- Track 8-6 Case study
- Track 9-1Bronchial carcinoma
- Track 9-2Oat Cell Carcinoma
- Track 9-3Squamous Cell Carcinoma
- Track 9-4Lung Carcinoma
- Track 10-1Head and neck cancers
- Track 10-2Gastrointestinal cancers
- Track 10-3Gynecologic and breast cancers
- Track 10-4 Hematologic cancers
- Track 10-5Robotics in oncological Surgery
- Track 10-6Translational approach in cancer treatment
- Track 11-1Metabolism of carcinogens
- Track 11-2Biological and external factors for carcinogenesis
- Track 11-3 Mutagenesis- Directed, Site-Specific and Mismatched
- Track 11-4Oncogenomics and proteomics
- Track 11-5Use of proteins as biomarkers and their role in carcinogenesis.
- Track 11-6The effects of environmental chemical carcinogens
- Track 12-1Lung Cancer Diagnosis and Treatment
- Track 12-2Lung Cancer Metastasis
- Track 12-3Advancements in Lung Cancer
- Track 12-4Chemo for Lung Cancer